HairGenics falsely claimed its hair loss pills were safe and clinically proven, a new class action lawsuit claims.

Carrie Saks filed a class action lawsuit against HairGenics LLC in the U.S. District Court for the Central District of California on Sept. 24, 2026.

The lawsuit alleges HairGenics marketed its Propidren hair growth supplement as safe and clinically proven to stop hair loss and regrow hair yet it contains unsafe ingredients that are not proven to treat hair loss.

HairGenics sells hair care products under the Propidren name. Its packaging and online product listings describe the products as dihydrotestosterone blockers that stimulates follicles, stop hair loss and regrow hair.

The allegations

The complaint claims Propidren contains saw palmetto, which the label lists as 200 mg of fruit with no extract or standardization. Clinical studies that reported hair benefits of saw palmetto allegedly used standardized extracts or multi-ingredient blends, which Propidren does not, the filing alleges

The lawsuit cites a National Center for Complementary and Integrative Health review that found the evidence for using saw palmetto for male-pattern hair loss too limited to draw conclusions.

Additionally, each two-capsule serving of Propidren reportedly contains 2 milligrams of biotin, more than 60 times the 30-microgram daily value. The U.S. Food and Drug Administration warned that biotin can interfere with lab tests, including the troponin tests doctors use to diagnose heart attacks, the lawsuit alleges.

The proposed class action also cites a 1965 study of 46 women that found those who took biotin had no change in their hair roots and a 2017 review that found too little evidence to support biotin use in healthy people.

Federal law treats products meant to treat or prevent disease as drugs, according to the complaint. It claims hair loss qualifies as a disease so marketing that describes preventing and reversing it makes Propidren an unapproved new drug under federal and California law.

The legal claims against HairGenics

The proposed class action brings six claims against HairGenics:


  • California Consumers Legal Remedies Act, which bars false claims about a product's benefits or quality

  • California Unfair Competition Law, which covers unlawful, unfair and fraudulent business practices

  • California False Advertising Law, which prohibits misleading ads

  • Breach of express warranty, which treats label claims as promises to buyers

  • Unjust enrichment, which seeks to recover profits the company made from sales

  • Nevada Deceptive Trade Practices Act, which bars knowingly false statements about goods for sale

Saks seeks restitution for buyers, extra damages meant to punish the company and a court order requiring HairGenics to stop the marketing claims at issue and run ads that correct them.

What the lawsuit means for Propidren buyers

The proposed nationwide class covers anyone in the United States who bought the supplement for personal, family or household use (not resale )within the applicable limitations period. A separate California subclass covers buyers in California.

There is no settlement, no claims process and no money available at this time.